MiR-625-5p is a potential therapeutic target in sepsis by regulating CXCL16/CXCR6 axis and endothelial barrier
Article in International Immunopharmacology (June 2024)
The most recent citing publications are shown below. View all 4 publications that cite this research output on Dimensions.
Article in International Immunopharmacology (June 2024)
Article in Chinese Medical Journal - Pulmonary and Critical Care Medicine (June 2024)
Article in Pharmacy Information (January 2024)